Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jan;86(1021):20120278.
doi: 10.1259/bjr.20120278.

The value of image-guided intensity-modulated radiotherapy in challenging clinical settings

S J Treece  1 , M Mukesh, Y L Rimmer, S J Tudor, J C Dean, R J Benson, D L Gregory, G Horan, S J Jefferies, S G Russell, M V Williams, C B Wilson, N G Burnet
Affiliations
Case Reports

The value of image-guided intensity-modulated radiotherapy in challenging clinical settings

S J Treece et al. Br J Radiol. 2013 Jan.

Abstract

Objective: To illustrate the wider potential scope of image-guided intensity-modulated radiotherapy (IG-IMRT), outside of the "standard" indications for IMRT.

Methods: Nine challenging clinical cases were selected. All were treated with radical intent, although it was accepted that in several of the cases the probability of cure was low. IMRT alone was not adequate owing to the close proximity of the target to organs at risk, the risk of geographical miss, or the need to tighten planning margins, making image-guided radiotherapy an essential integral part of the treatment. Discrepancies between the initial planning scan and the daily on-treatment megavoltage CT were recorded for each case. The three-dimensional displacement was compared with the margin used to create the planning target volume (PTV).

Results: All but one patient achieved local control. Three patients developed metastatic disease but benefited from good local palliation; two have since died. A further patient died of an unrelated condition. Four patients are alive and well. Toxicity was low in all cases. Without daily image guidance, the PTV margin would have been insufficient to ensure complete coverage in 49% of fractions. It was inadequate by >3 mm in 19% of fractions, and by >5 mm in 9%.

Conclusion: IG-IMRT ensures accurate dose delivery to treat the target and avoid critical structures, acting as daily quality assurance for the delivery of complex IMRT plans. These patients could not have been adequately treated without image guidance.

Advances in knowledge: IG-IMRT can offer improved outcomes in less common clinical situations, where conventional techniques would provide suboptimal treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Case 1, pelvic Ewing's sarcoma.
Figure 2
Figure 2
Case 2, chest wall chondrosarcoma.
Figure 3
Figure 3
Case 3, prostate adenocarcinoma.
Figure 4
Figure 4
Case 4, carcinoma of the larynx.
Figure 5
Figure 5
Case 5, prostate and rectal adenocarcinomas.
Figure 6
Figure 6
Case 6, carcinoma of the cervical oesophagus.
Figure 7
Figure 7
Case 7, recurrent nasopharyngeal carcinoma.
Figure 8
Figure 8
Case 8, cervical carcinoma.
Figure 9
Figure 9
Case 9, vertebral chordoma.
See this image and copyright information in PMC

References

    1. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981–91. - PubMed
    1. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, et al. Breast Technology Group Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007;82:254–64. - PubMed
    1. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008;9:367–75. - PubMed
    1. Staffurth J. A review of the clinical evidence for intensity modulated radiotherapy. Clin Oncol (R Coll Radiol) 2010;22:643–57. - PubMed
    1. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127–36. - PMC - PubMed

Publication types